PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of ...
At a time when biotech is increasingly central to global health, and climate resilience, GenScript’s ESG Report demonstrates how the company is embedding sustainability, governance, and societal ...
Chimeric antigen receptor T cell (CAR T) therapies have transformed the treatment of blood cancers, delivering durable responses in patients with limited options. But CAR T therapies are complex and ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
Founded in 2002 in New Jersey, GenScript Biotech Corporation operates through three core businesses; GenScript Life Science Group, ProBio, and Bestzyme. The Group accelerates innovation in biotech & ...
Reinforcing Europe as a core pillar of GenScript’s global R&D and production network GenScript has opened its first European mRNA production site in Delft, the Netherlands, marking an expansion of the ...
PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental ...
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results